Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study investigates changing patterns of SARS-CoV-2 infection through Delta and Omicron waves

A new study examined whether SARS-CoV-2 infections in England varied by vaccination status, in cases with a previous COVID-19 positive test report individual, and by neighborhood socioeconomic deprivation, across the Delta and Omicron waves.

7 Apr 2022

Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

Researchers conducted a controlled, double-blinded Phase III trial to evaluate the efficacy of SARS-CoV-2) hyperimmune globulin in immunocompromised hospitalized COVID-19 patients.

7 Apr 2022

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

A new study investigates the combination of two small molecules that target the host cells and reports a synergistic antiviral activity in vitro against SARS-CoV-2.

7 Apr 2022

Sotrovimab found to prevent hospitalization and mortality in COVID-19 outpatients

Researchers tested the efficacy of sotrovimab in non-hospitalized patients with SARS-CoV-2 infection.

7 Apr 2022

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

A recent article presented the diverse pathogenesis of SARS-CoV-2 variants of concern in a humanized mouse model.

7 Apr 2022

Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses

Researchers analyzed the influence of the use of spectacles on COVID-19 risk in a community setting.

7 Apr 2022

Study finds vaccines effectively reduce deaths from COVID-19 but not the prevalence of infections

Researchers in Australia have investigated COVID-19 vaccine effectiveness on the prevalence and mortality of the Delta variant.

7 Apr 2022

An assessment of COVID-19 vaccine safety during pregnancy

In a recent study posted to the Preprints with The Lancet* SSRN preprint server, researchers evaluated the safety of currently administered coronavirus disease 2019 (COVID-19) vaccines in child-bearing women.

7 Apr 2022

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

A recent study posted to the medRxiv* preprint server investigated the elements that predicted all-cause mortality among individuals hospitalized due to influenza, respiratory syncytial virus (RSV), or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

7 Apr 2022

SARS-CoV-2 spike S375F mutation triggered the explosive spread of Omicron

In a recent study posted to the bioRxiv* preprint server, researchers investigated the mutation in the viral spike (S) protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 variant (referred to as Omicron in the present study) that is responsible for the variant’s virological features.

7 Apr 2022

SARS-CoV-2 transmission in first few X cases and households

In a study posted to the medRxiv* preprint server, researchers conducted a systematic review and meta-analysis to determine the household secondary infection attack rate (hSAR) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

6 Apr 2022

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

A recent study posted to the medRxiv* preprint server investigated the association of renin-angiotensin-aldosterone system (RAAS)-mediated hypertension (HT) with coronavirus disease 2019 (COVID-19).

6 Apr 2022

Israeli research confirms BNT162b2 booster's effectiveness

Researchers explore the use of a third dose of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

6 Apr 2022

How effective are mRNA boosters against to Delta and Omicron?

The current study discusses available data on the effectiveness of mRNA vaccination against Omicron.

6 Apr 2022

COVID boosters protect you better than monoclonal antibodies, or natural infection

In a new study published in the journal Science Translational Medicine, researchers analyzed the neutralization of the Omicron BA.1 variant pseudovirus by post-vaccination serum samples.

6 Apr 2022

COVID-19 protection increases after fourth vaccine dose but declines quickly

A new study published in The New England Journal of Medicine has focussed on the relative effectiveness of the fourth dose, compared to the three doses vaccination regime, against confirmed infection and severe illness among older persons in the Israeli population.

6 Apr 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study investigates changing patterns of SARS-CoV-2 infection through Delta and Omicron waves

Efficacy of SARS-CoV-2 hyperimmune globulin in treatment of severely immunocompromised hospitalized COVID-19 patients

Study explores broad-spectrum, host-acting antiviral strategy to treat SARS-CoV-2

Sotrovimab found to prevent hospitalization and mortality in COVID-19 outpatients

Insights into the pathogenesis of the previous and circulating SARS-CoV-2 variants in mice

Study finds a significant reduction in the risk of COVID-19 infection among those who always wear glasses

Study finds vaccines effectively reduce deaths from COVID-19 but not the prevalence of infections

An assessment of COVID-19 vaccine safety during pregnancy

Patient outcomes after influenza, RSV, or SARS-CoV-2 hospitalization

SARS-CoV-2 spike S375F mutation triggered the explosive spread of Omicron

SARS-CoV-2 transmission in first few X cases and households

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

Israeli research confirms BNT162b2 booster's effectiveness

How effective are mRNA boosters against to Delta and Omicron?

COVID boosters protect you better than monoclonal antibodies, or natural infection

COVID-19 protection increases after fourth vaccine dose but declines quickly

Study explores incidence of cardiac impairment a year after SARS-CoV-2 infection

Adolescents’ pandemic-related health literacy and how protective measures affect their quality of life

Evaluating clinical and economic impact of varying COVID-19 booster effectiveness in the US

Investigating high rate of Omicron sublineage breakthrough infections in triple vaccinated healthcare workers

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in